{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:53:13Z","timestamp":1772985193750,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejim.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T14:30:45Z","timestamp":1502202645000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Current status of therapeutic and vaccine approaches against Zika virus"],"prefix":"10.1016","volume":"44","author":[{"given":"Braira","family":"Wahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazia","family":"Rafique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00705-005-0626-6","article-title":"A multigene analysis of the phylogenetic relationships among the flaviviruses (family: Flaviviridae) and the evolution of vector transmission","volume":"151","author":"Cook","year":"2006","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002636","article-title":"Molecular evolution of Zika virus during its emergence in the 20th century","volume":"8","author":"Faye","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"03","key":"10.1016\/j.ejim.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3855\/jidc.8350","article-title":"Zika virus: a new pandemic threat","volume":"10","author":"Al-Qahtani","year":"2016","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12985-016-0623-2","article-title":"Zika virus on a spreading spree: what we now know that was unknown in the 1950's","volume":"13","author":"Basu","year":"2016","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.ejim.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apjtm.2016.06.019","article-title":"Zika: as an emergent epidemic","volume":"9","author":"Wahid","year":"2016","journal-title":"Asian Pac J Trop Med"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005528","article-title":"Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: a systematic review","volume":"11","author":"Colt","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.ejim.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jir.2017.0011","article-title":"Maternal-fetal transmission of zika virus: routes and signals for infection","volume":"37","author":"Cao","year":"2017","journal-title":"J Interf Cytokine Res"},{"issue":"7","key":"10.1016\/j.ejim.2017.08.001_bb0040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/trf.13681","article-title":"Probable transfusion-transmitted Zika virus in Brazil","volume":"56","author":"Barjas-Castro","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.ejim.2017.08.001_bb0045","author":"World Health Organization (WHO)"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5501\/wjv.v5.i4.135","article-title":"Neurological manifestations of Zika virus infection","volume":"5","author":"Bl\u00e1zquez","year":"2016","journal-title":"World Journal of Virology"},{"key":"10.1016\/j.ejim.2017.08.001_bb0055","first-page":"16023","article-title":"Zika vaccine candidates progress through nonclinical development and enter clinical trials. npj","volume":"1","author":"Barrett","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ejim.2017.08.001_bb0060","article-title":"Identifying candidate targets of immune responses in Zika virus based on homology to epitopes in other Flavivirus species","volume":"8","author":"Xu","year":"2016","journal-title":"PLoS Currents"},{"key":"10.1016\/j.ejim.2017.08.001_bb0065","series-title":"Development of recombinant ZIKV vaccine based on subunit envelope (E) antigen fused to TLR5 agonist (flagellin)","author":"Ge","year":"2016"},{"issue":"7617","key":"10.1016\/j.ejim.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"issue":"6304","key":"10.1016\/j.ejim.2017.08.001_bb0075","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0080","doi-asserted-by":"crossref","DOI":"10.4172\/jaa.1000e130","article-title":"Zika virus: prospects for the development of vaccine and antiviral agents","volume":"8","author":"Awasthi","year":"2016","journal-title":"J Antivir Antiretrovir"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0085","doi-asserted-by":"crossref","DOI":"10.15406\/mojpb.2016.03.00084","article-title":"Zeka virus therapeutics: drug targets and repurposing medicine from the human genome","volume":"3","author":"Narayanan","year":"2016","journal-title":"MOJ Proteomics Bioinform"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0090","doi-asserted-by":"crossref","DOI":"10.15406\/mojpb.2016.03.00088","article-title":"Zika virus therapeutic lead compounds discovery using chemoinformatics approaches","volume":"3","author":"Narayanan","year":"2016","journal-title":"MOJ Proteomics Bioinform"},{"key":"10.1016\/j.ejim.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ebiom.2016.09.028","article-title":"Preventative vaccines for Zika virus outbreak: preliminary evaluation","volume":"13","author":"Kim","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejim.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.ejim.2017.08.001_bb0105","series-title":"The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication","first-page":"061671","author":"Sacramento","year":"2016"},{"key":"10.1016\/j.ejim.2017.08.001_bb0110","series-title":"Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library","first-page":"5","author":"Pascoalino","year":"2016"},{"issue":"2","key":"10.1016\/j.ejim.2017.08.001_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of Zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01123-16","article-title":"Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus","volume":"7","author":"Swanstrom","year":"2016","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/cr.2016.144","article-title":"Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring","volume":"27","author":"Wang","year":"2016","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice","volume":"21","author":"Ngono","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejim.2017.08.001_bb0140","first-page":"e54767","article-title":"Zika virus infectious cell culture system and the in vitro prophylactic effect of interferons","volume":"114","author":"Contreras","year":"2016","journal-title":"JoVE (J Vis Exp)"},{"issue":"13","key":"10.1016\/j.ejim.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMp1607762","article-title":"Considerations for developing a Zika virus vaccine","volume":"375","author":"Marston","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.08.001_bb0150","series-title":"Development of a Zika vaccine","author":"Tripp","year":"2016"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0975-2870.197899","article-title":"Zika virus: vaccine initiatives and obstacles","volume":"10","author":"Mukherjee","year":"2017","journal-title":"Medical Journal of Dr DY Patil University"},{"key":"10.1016\/j.ejim.2017.08.001_bb0160","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/npjvaccines.2016.7","article-title":"Research and development of Zika virus vaccines","volume":"1","author":"Dawes","year":"2016","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0165","doi-asserted-by":"crossref","DOI":"10.4172\/jaa.1000e130","article-title":"Zika virus: prospects for the development of vaccine and antiviral agents","volume":"8","author":"Awasthi","year":"2016","journal-title":"Journal of Antivirals & Antiretrovirals"},{"issue":"13","key":"10.1016\/j.ejim.2017.08.001_bb0170","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJMp1609300","article-title":"Fast-track Zika vaccine development\u2014is it possible?","volume":"375","author":"Thomas","year":"2016","journal-title":"N Engl J Med"},{"issue":"34","key":"10.1016\/j.ejim.2017.08.001_bb0175","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.vaccine.2016.03.059","article-title":"Another emerging arbovirus, another emerging vaccine: targeting Zika virus","volume":"20","author":"Palacios","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cmi.2016.03.001","article-title":"Zika as still another argument for a new path to vaccine development","volume":"22","author":"Plotkin","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2017.08.001_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/srep32713","article-title":"ZikaVR: an integrated Zika virus resource for genomics, proteomics, phylogenetic and therapeutic analysis","volume":"6","author":"Gupta","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2017.08.001_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.08.001_bb0195","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ejim.2017.08.001_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2016.10.016","article-title":"Pushing forward with Zika vaccines","volume":"13","author":"Kennedy","year":"2016","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ejim.2017.08.001_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0210","first-page":"389","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"4","author":"Hamdy","year":"2015","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2016.09.020","article-title":"Zika virus: immunity and vaccine development","volume":"167","author":"Pierson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2017.08.001_bb0220","series-title":"Zika research projects list: ZIKAVax project: the exosome technology as promising platform for the development of a candidate vaccine against Zika virus","author":"Viranaicken","year":"2016"},{"key":"10.1016\/j.ejim.2017.08.001_bb0225","series-title":"Zika virus is a candidate for application of nanofibre based system for noninvasive sublingual immunisation: new technology platform for printed vaccines","author":"Tur\u00e1nek","year":"2016"},{"issue":"12","key":"10.1016\/j.ejim.2017.08.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005168","article-title":"Heterologous protection against Asian Zika virus challenge in rhesus macaques","volume":"10","author":"Aliota","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ejim.2017.08.001_bb0235","series-title":"Trials of Zika vaccine are set to begin in North America","author":"Dyer","year":"2016"},{"key":"10.1016\/j.ejim.2017.08.001_bb0240","first-page":"aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.08.001_bb0250","series-title":"Vaccine development for Zika virus\u2014timelines and strategies. In seminars in reproductive medicine","author":"Durbin","year":"2016"},{"issue":"8","key":"10.1016\/j.ejim.2017.08.001_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003025","article-title":"Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions","volume":"8","author":"Whitehorn","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ejim.2017.08.001_bb0260","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","author":"Kuivanen","year":"2016","journal-title":"Antivir Res"},{"issue":"10","key":"10.1016\/j.ejim.2017.08.001_bb0265","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12916-016-0636-0","article-title":"Antibiotic use during pregnancy: how bad is it?","volume":"14","author":"Kuperman","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.ejim.2017.08.001_bb0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antivir Res"},{"issue":"10","key":"10.1016\/j.ejim.2017.08.001_bb0280","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.celrep.2016.08.038","article-title":"Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia","volume":"16","author":"Onorati","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejim.2017.08.001_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jviromet.2016.09.015","article-title":"A sensitive virus yield assay for evaluation of antivirals against Zika virus","volume":"238","author":"Goebel","year":"2016","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.ejim.2017.08.001_bb0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.ejim.2017.08.001_bb0295","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.ejim.2017.08.001_bb0300","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Virus"},{"issue":"5","key":"10.1016\/j.ejim.2017.08.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2\u2032-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0310","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s40506-016-0083-7","article-title":"Zika virus: where is the treatment?","volume":"8","author":"Mumtaz","year":"2016","journal-title":"Current Treatment Options in Infectious Diseases"},{"key":"10.1016\/j.ejim.2017.08.001_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.ejim.2017.08.001_bb0320","first-page":"411","article-title":"Clinical trials of therapeutics for the prevention of congenital Zika virus disease: challenges and potential solutions clinical trials of therapeutics to prevent congenital ZIKV disease","volume":"28","author":"Salam","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2017.08.001_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00411-17","article-title":"Zika virus: a race in search for antivirals","author":"Saiz","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejim.2017.08.001_bb0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","article-title":"The green tea molecule EGCG inhibits Zika virus entry","volume":"496","author":"Carneiro","year":"2016","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0335","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","article-title":"25-Hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model","volume":"46","author":"Li","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5808\/GI.2016.14.3.104","article-title":"Virtual screening for potential inhibitors of NS3 protein of Zika virus","volume":"14","author":"Sahoo","year":"2016","journal-title":"Genome Inform"},{"key":"10.1016\/j.ejim.2017.08.001_bb0345","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2016.12.058","article-title":"2, 8-bis (trifluoromethyl) quinoline analogs show improved anti-Zika virus activity, compared to mefloquine","volume":"127","author":"Barbosa-Lima","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ejim.2017.08.001_bb0350","series-title":"Adenosine analog NITD008 is a potent inhibitor of Zika virus. In Open forum infectious diseases","author":"Deng","year":"2016"},{"key":"10.1016\/j.ejim.2017.08.001_bb0355","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.ejim.2017.08.001_bb0360","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.ejim.2017.08.001_bb0365","article-title":"Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication","author":"L","year":"2017","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ejim.2017.08.001_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00350-17","article-title":"N-methyl\u2011d-aspartate (NMDA) receptor blockade prevents neuronal death induced by Zika virus infection","volume":"8","author":"Costa","year":"2017","journal-title":"MBio"},{"issue":"196","key":"10.1016\/j.ejim.2017.08.001_bb0375","first-page":"49","article-title":"Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids","volume":"49","author":"Fagbami","year":"1986","journal-title":"Cytobios"},{"key":"10.1016\/j.ejim.2017.08.001_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/838491","article-title":"Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections","volume":"2013","author":"Sautto","year":"2013","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.ejim.2017.08.001_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"issue":"7633","key":"10.1016\/j.ejim.2017.08.001_bb0390","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejim.2017.08.001_bb0395","first-page":"342","article-title":"T-cell therapy for viral infections","volume":"2013","author":"Heslop","year":"2013","journal-title":"ASH Education Program Book"},{"issue":"6","key":"10.1016\/j.ejim.2017.08.001_bb0400","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika virus targets human STAT2 to inhibit type I interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.ejim.2017.08.001_bb0405","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embr.201642627","article-title":"Zika virus inhibits type-I interferon production and downstream signaling","volume":"17","author":"Kumar","year":"2016","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.ejim.2017.08.001_bb0410","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","article-title":"Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection","volume":"19","author":"Bayer","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejim.2017.08.001_bb0415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.11.020","article-title":"Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase","volume":"137","author":"Herc\u00edk","year":"2017","journal-title":"Antivir Res"},{"issue":"5","key":"10.1016\/j.ejim.2017.08.001_bb0420","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A mouse model of Zika virus pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejim.2017.08.001_bb0425","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2017.08.001_bb0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.ejim.2017.08.001_bb0435","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ejim.2017.08.001_bb0440","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:53:54Z","timestamp":1535565234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517303035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":87,"alternative-id":["S0953620517303035"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of therapeutic and vaccine approaches against Zika virus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}